10245718

An ‘Atlas’ to Count the Genes
This article details the ambitious plans of a newly formed company called Confirmant to offer a catalog of human proteins. Many are skeptical of Confirmant’s claims – this article investigates the issue.

10242627

From Skin Creams to Life Insurance to Medical Care, Biosciences Are the New Frontier of Business Opportunity
“Research in the biological sciences holds the potential for breakthroughs that could transform the world. But scientific advances also can be baffling and more than a little intimidating, especially for business people.”

10242616

Cloning: Fat Mice And Copy Cats
“Certain cloned mice become more obese than mice that were born by normal means or conceived in a test tube … while these rodents are rotund as a result of the cloning process, their offspring seem completely normal.” An overview of cloning concerns and practical considerations.

10157907

FDA Gets a Temporary Boss
Following months of a headless FDA that has been blamed for slowing drug approvals and being unreasonably conservative. Dr. Lester Crawford, who most recently directed the Center for Food and Nutrition Policy, was named deputy commissioner of the FDA.

10131076

Solid Gold Sales
“In the music industry, a gold record goes to the artist whose music hits the top of the charts — and stays there. Sales of 500,000 copies guarantee solid gold status; sales of one million catapult it to platinum.
In the biotech sector, the gold goes to those companies that develop and market superior products. Annual sales of at least $200 million guarantee a slot on the best-seller list; sales of one billion push it over the top.”

10131012

Better Careers (and Wine) Through Biotech
Increasing biotechnology spending on R&D is motivating individuals to retrain for careers in biotechnology. This article introduces the University of California Extension, Santa Cruz Biotechnology Certificate Program offering information technology professionals as well as chemists, biologists, and other scientists courses in the techniques and technologies of biotech

10130829

The Biotech Industry: Right on Target
“Despite the current economic slump, investing in biotech remains steady. Here’s where the money is going, and predictions for the hot trends of the future.”

9986248

Biotech offerings can’t shake the chill
If you were hoping that the market for biotechnology IPOs was going to bounce back early this year, you’ll have to wait.

9974681

Protein Microarrays May Just Be the Next Big (Little) Thing
Protein arrays have the potential to dramatically improve the pace and scale of protein research as DNA microarrays have done for DNA. Technical challenges related to producing arrays are being resolved, but the question of reproducibility and relevance of results remains.

9970583

Angel Financing: It’s All a Matter of Control
But there is value in losing a little control: You give up something to get quite a bit in return. Consider the angel funding process in that light, and you’re sure to come away with the results tilting in your favor.